Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Rubab Z, Amin H, Abbas K, Hussain S, Ullah I, Mohsin S (2015) Serum hepcidin levels in patients with end-stage renal disease on hemodialysis. Saudi J Kidney Dis Transplant 26(1):19–25
2. KDOQI; National Kidney Foundation (2006) KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47(5 Suppl 3):S11–S145
3. Sibbel S, Koro C, Brunelli S, Cobitz R (2015) Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients. BMC Nephrol 16:144–154
4. Ogawa T, Nitta K (2015) Erythropoiesis-stimulating agent hyporesponsiveness in end-stage renal disease patients. Contrib Nephrol 185:76–86
5. Weiss G, Theurl I, Eder S, Koppelstaetter C, Kurz K, Sonnweber T et al (2009) Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Eur J Clin Investig 39(10):883–890
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献